You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 14, 2024

CLINICAL TRIALS PROFILE FOR ETHOSUXIMIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Ethosuximide

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00088452 ↗ Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study Completed National Institute of Neurological Disorders and Stroke (NINDS) Phase 3 2004-07-01 The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00088452 ↗ Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study Completed Children's Hospital Medical Center, Cincinnati Phase 3 2004-07-01 The purpose of this study is to determine the best initial treatment for childhood absence epilepsy.
NCT00689585 ↗ Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated McGill University Phase 2 2008-09-01 Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT00689585 ↗ Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated McGill University Health Center Phase 2 2008-09-01 Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT00689585 ↗ Safety and Efficacy Study of Ethosuximide for the Treatment of Complex Regional Pain Syndrome (CRPS) Terminated McGill University Health Centre/Research Institute of the McGill University Health Centre Phase 2 2008-09-01 Pain remains the most debilitating symptom for adult patients suffering from complex regional pain syndrome (CRPS). Most CRPS patients gain little to no relief from current painkillers. The purpose of this study is to evaluate the efficacy and safety of ethosuximide in search of much-needed adjunctive therapy to relieve the pain and suffering associated with CRPS.
NCT01122381 ↗ Comparison of a Drug and Placebo in the Prevention of Migraine Headaches Terminated Thomas Jefferson University Phase 1/Phase 2 2011-12-01 The purpose of this study is to determine whether ethosuximide works better than placebo in the prevention of episodic migraine among veterans.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Ethosuximide

Condition Name

Condition Name for Ethosuximide
Intervention Trials
Peripheral Neuropathic Pain 2
Epilepsy 2
IBS - Irritable Bowel Syndrome 1
Irritable Bowel Syndrome 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Ethosuximide
Intervention Trials
Epilepsy 4
Syndrome 3
Epilepsy, Absence 2
Irritable Bowel Syndrome 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Ethosuximide

Trials by Country

Trials by Country for Ethosuximide
Location Trials
United States 24
France 4
United Kingdom 3
Egypt 2
Canada 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Ethosuximide
Location Trials
Pennsylvania 2
Alabama 1
Ohio 1
Oregon 1
Tennessee 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Ethosuximide

Clinical Trial Phase

Clinical Trial Phase for Ethosuximide
Clinical Trial Phase Trials
Phase 4 2
Phase 3 3
Phase 2 5
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Ethosuximide
Clinical Trial Phase Trials
Recruiting 4
Unknown status 3
Completed 3
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Ethosuximide

Sponsor Name

Sponsor Name for Ethosuximide
Sponsor Trials
University Hospital, Clermont-Ferrand 3
US Department of Veterans Affairs 1
Central Manchester University Hospitals NHS Foundation Trust 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Ethosuximide
Sponsor Trials
Other 35
U.S. Fed 2
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.